FDA says rules on prescription drug tracking will take effect in December

[JURIST] The US Food and Drug Administration [official website] said Friday that new rules [press release] requiring wholesalers to be able to track prescription drugs will take effect in December. The rules stem from the Prescription Drug Marketing Act of 1987 [summary], a law aimed at combating drug counterfeiting [FDA backgrounder]. The FDA has so far been unable to fully enforce this law due to a lack of practical means to do so. Certain regulations requiring distributors to document the "pedigree" of drug products [draft compliance policy guide] had been delayed due to a concern about their impact on small wholesalers, but in a report [text] Friday, the FDA said that "it can no longer justify not implementing these regulations." The advent of radio frequency identification tags technology (RFID) [Wikipedia backgrounder] now allows wholesalers to more effectively and efficiently track individual bottles.

According to the World Health Organization [official website], counterfeiting involves between 8 and 10 percent of all drugs sold. FDA acting Commissioner Dr. Andrew C. von Eschenbach [official profile] has said that the use of RFID tags will help to reduce the risk that these counterfeit drugs will enter the US market. The New York Times has more.

 

About Paper Chase

Paper Chase is JURIST's real-time legal news service, powered by a team of 30 law student reporters and editors led by law professor Bernard Hibbitts at the University of Pittsburgh School of Law. As an educational service, Paper Chase is dedicated to presenting important legal news and materials rapidly, objectively and intelligibly in an accessible format.

© Copyright JURIST Legal News and Research Services, Inc., 2013.